Enbrel Deceleration Continues: Firm Cites End Of Oral Demo As New Speed Bump
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm recently begun a rheumatology ad campaign for TNF inhibitor etanercept; a dermatology television ad is yet to come.
You may also be interested in...
Amgen Will Have Day In Court With Roche
The company also reports that sales of its TNF inhibitor Enbrel are “not meeting expectations.”
Amgen Will Have Day In Court With Roche
The company also reports that sales of its TNF inhibitor Enbrel are “not meeting expectations.”
Enbrel Growth Plans Include Copay Assistance, DTC
Market share has stabilized but Amgen acknowledges that the TNF inhibitor “isn’t performing up to our expectations.”